Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of disclosure in relation to number of Equity Shares tendered in connection with the Open Offer ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Citigroup Global Markets India, acting as Manager to the Open Offer, has reported the number of shares tendered by public shareholders of Sanofi Consumer Healthcare India in the ongoing Open Offer by Opal Bidco SAS (along with Clayton, Dubilier & Rice Fund XII as a person acting in concert). As of May 9, 2025, a total of 25,04,630 equity shares have been tendered, representing 41.83% of the Offer Size of up to 59,87,962 shares (26% of voting share capital). Only 52,054 of these shares (0.87% of the Offer Size) were tendered on the reporting day itself. The Letter of Offer was dated April 12, 2025, and shares will be accepted subject to validation under SEBI takeover rules.
The tender response is a routine daily disclosure showing healthy public participation (over 41% of the offer already tendered). This is largely procedural and is unlikely to move the stock price on its own, but it indicates steady acceptance of the acquirer's offer price by public shareholders.